Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 41 (3) , 475-484
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute
This publication has 88 references indexed in Scilit:
- Inhaled corticosteroids in COPD and the risk of serious pneumoniaThorax, 2013
- Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Placebo-Controlled TrialAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studiesThorax, 2011
- Cardiovascular events in patients with COPD: TORCH Study resultsThorax, 2010
- Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary DiseaseDrugs, 2009
- Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatmentEuropean Respiratory Journal, 2006
- Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary diseaseEuropean Respiratory Journal, 2003
- Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasoneAnnals of Allergy, Asthma & Immunology, 2003
- Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialThe Lancet, 2003
- The use of high dose inhaled beclomethasone dipropionate as a means of assessing steroid responsiveness in obstructive airways diseaseRespiratory Medicine, 1988